Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist

Name: Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist
SKU: 8213
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 47 No. 4 Articles - 2017 Tags: adverse-effects, Dorothy Gotlib, drug information, drug-interactions, Elizabeth Perelstein, Jacob E. Kurlander, jolene-r-bostwick, psychopharmacology, quality-of-health-care, referral and consultation, Seema Calip, Thomas Fluent

Description

Description

General Psychiatry

Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist

By Dorothy Gotlib, Jolene R. Bostwick, Seema Calip, Elizabeth Perelstein, Jacob E. Kurlander, Thomas Fluent

53-58_PB-47-4-2017_PB-Gotlib

Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist

Description

General Psychiatry

Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist

By Dorothy Gotlib, Jolene R. Bostwick, Seema Calip, Elizabeth Perelstein, Jacob E. Kurlander, Thomas Fluent

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Assessing Rates and Predictors of Tachyphylaxis

Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist

Description

General Psychiatry

Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist

By Dorothy Gotlib, Jolene R. Bostwick, Seema Calip, Elizabeth Perelstein, Jacob E. Kurlander, Thomas Fluent

Related products

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Assessing Rates and Predictors of Tachyphylaxis